Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALGORAE PHARMACEUTICALS LIMITED Director's Dealing 2010

Sep 23, 2010

64249_rns_2010-09-23_dd82b994-781d-447e-9fee-8d47ebb0c044.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LIMITED ABN 14 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director PAUL TAN
Date of last notice 4 JANUARY 2010
Date that director ceased to be director 23 SEPTEMBER 2010

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

208,571 FULLY PAID ORDINARY SHARES (HELD BY PAUL LIP JIN TAN)

300,000 OPTIONS EXERCISABLE AT $0.30 EACH EXPIRING 15 NOVEMBER 2010 HELD BY PAUL LIP JIN TAN

500,000 OPTIONS EXERCISABLE AT $0.20 EACH, VESTING ON 23 APRIL 2008 AND EXPIRING 15/11/2010 HELD BY PAUL LIP JIN TAN

500,000 OPTIONS EXERCISABLE AT $0.30 EACH, VESTING ON 23 FEBRUARY 2008 AND EXPIRING 07/03/2013 HELD BY PAUL LIP JIN TAN

  • See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise tothe relevant interestN/A Number & class of securities

Part 3 – Director’s interests in contracts

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
No. and class of securities to whichinterest relates
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002